Liquidia stock jumps after $148.3 million YUTREPIA sales update — what LQDA investors watch next week
Shares of Liquidia Corporation jumped 12.9% to close at $35.86 on Friday, following a strong sales surge for its inhaled treprostinil therapy, YUTREPIA. The stock traded between $29.41 and $38.07 throughout the day.